University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Palliation of Thirst in ICU Patients

Early Phase 1

Completed

Conditions: Thirst

Interventions: Behavioral: combined therapy treatment

First Posted Date: 2009-11-18

Last Posted Date: 2013-03-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 353

Registration Number: NCT01015755

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Treating to Target for Patients With Hypertension

Not Applicable

Completed

Conditions: Hypertension

Interventions: Behavioral: Health coaching plus home titration
Behavioral: Health coaching

First Posted Date: 2009-11-16

Last Posted Date: 2022-03-21

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 240

Registration Number: NCT01013857

Locations: 🇺🇸
San Francisco General Hospital, San Francisco, California, United States

Safety and Efficacy Study of Combination Treatment With Excimer Laser, Clobex Spray, and Vectical Ointment in the Treatment of Psoriasis

Phase 4

Completed

Conditions: Chronic Stable Plaque Psoriasis

Interventions: Drug: Clobex Spray
Drug: Vectical Ointment
Procedure: Excimer Laser

First Posted Date: 2009-11-13

Last Posted Date: 2015-06-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT01012713

Locations: 🇺🇸
UCSF Psoriasis and Skin Treatment Center, San Francisco, California, United States

Trial Comparing Intravenous and Oral Moderate Sedation for First Trimester Surgical Abortions

Phase 4

Terminated

Conditions: Undesired Intrauterine Pregnancy
First Trimester Pregnancy

Interventions: Drug: Intravenous moderate sedation versus oral medication

First Posted Date: 2009-11-11

Last Posted Date: 2013-05-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 18

Registration Number: NCT01011634

Locations: 🇺🇸
San Francisco General Hospital, San Francisco, California, United States

Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma

Phase 2

Terminated

Conditions: Glioblastoma

First Posted Date: 2009-11-11

Last Posted Date: 2013-05-06

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1

Registration Number: NCT01011231

Locations: 🇺🇸
UCSF Department of Neurosurgery, San Francisco, California, United States

A Pilot Clinical Trial of Varenicline as a Treatment for Alcohol Dependence

Not Applicable

Completed

Conditions: Substance Dependence

Interventions: Drug: placebo
Drug: varenicline

First Posted Date: 2009-11-11

Last Posted Date: 2013-02-25

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 99

Registration Number: NCT01011907

Locations: 🇺🇸
UCSF: Ernest Gallo Clinic and Research Center, Emeryville, California, United States

Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer

Interventions: Drug: VPA FEC100

First Posted Date: 2009-11-10

Last Posted Date: 2018-03-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 6

Registration Number: NCT01010854

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Study of Blood and Cheek Cell Samples From Patients With Glioma

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2009-11-06

Last Posted Date: 2019-07-22

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1709

Registration Number: NCT01009307

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma

Phase 1

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Drug: sorafenib with temsirolimus

First Posted Date: 2009-11-06

Last Posted Date: 2019-05-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 25

Registration Number: NCT01008917

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, United States
🇺🇸
University of California San Francisco, San Francisco, California, United States

Protein Synthesis in Midthigh Muscles PET/CT

Completed

Conditions: Sarcopenia

First Posted Date: 2009-11-06

Last Posted Date: 2011-05-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT01008839

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy